Navigation Links
Teva to Acquire Barr
Date:7/18/2008

7) 224-4324 Internationally and using the participant code 49487796. The call will also be webcast and can be accessed through the Companies' websites at http://www.tevapharm.com and http://www.barrlabs.com. A replay of the conference call will be available from 10:30 AM Eastern time on July 18 through 11:59 PM Eastern time on July 25 and can be accessed by dialing (888) 286-8010 in the United States or (617) 801-6888 Internationally and using the passcode 33090437.

About Teva

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.

About Barr

Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. A holding company, Barr operates through its principal subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidiaries. The Barr Group of companies markets more than 120 generic and 27 proprietary products in the U.S. and approximately 1,025 products globally outside of the U.S. For more information, visit http://www.barrlabs.com.

Safe Harbor Statement under the U. S. Private Securities Litigation Reform Act of 1995:

The statements, analyses and other information contained herein relating to the proposed merger and anticipated synergies, savings and financial and operating performance, including estimates
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Neogen Acquires Kane Enterprises
4. Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
5. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
6. Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek
7. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
8. NSF International Acquires David Begg Associates
9. United BioSource Acquires Caro Research, Leader in Simulation Modeling
10. Groupe Novasep to Acquire PharmaChem Technologies (Grand Bahama) Ltd
11. Bristol-Myers Squibb to Acquire Adnexus Therapeutics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...STON,Nov.25/PRNewswire/--BiotechfirmReplikinsLtd.,...8pandemicthroughtheprediction,outbreak,andprogress...emicalanalysisofthevirus.Thenewdatashowsthatthelet...eakof3.7(s.d.4.5)duringthevirus,scurrentoutbreakin...of2.0(s.d.0.1).TheH1N1virus,infectivitycount,howev...
(Date:11/25/2009)...WYORK,Nov.25/PRNewswire/--Reportlinker.comannounce...ogue: ,, BrazilBioethanolMarketAnalysisandFore...165503/Brazil-Bioethanol-Market-Analysis-and-Forec...lysisandForecaststo2013 ,, Summary ,, Ther...albioethanolmarketandtheBrazilbioethanolmarketinpa...
(Date:11/24/2009)... The New York investment bank KTA C...U) has agreed an AU$6.7 mil convertible note priva...he private placement was arranged by KTA Capital a... , New York (PRWEB) Novemb... bank KTA Capital, LLC ("KTA Capital") h...
(Date:11/24/2009)... Health care employment grew by 2...nly one to show consistent growth during the U.S. ...s remain in trouble, and health systems are coming...l, instead of just administrators. , ...re employment continued growing in October despite...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...edical Systems, Growing Network of Medical Technol...Year of Profitability in 2007., PLEASANTON, Calif...an office in Russia to open a distribution network...lted in the registration of DMS,s,InNovaSound USB ... medical,providers in Russia., (Logo: http://www...
..., Calif., May 16 Immunosyn,Corporation (OTC Bulle...tained exclusive worldwide marketing, sales and di... from its affiliate Argyll Biotechnologies,LLC, ha...ch 31, 2008., For the quarter ended March 31, 200... administrative expenses and $13,393.00 in interes...
..., Calif., May 16 InterMune, Inc.,(Nasdaq: ITMN )...esident and,Chief Financial Officer of InterMune, ...re Conference in New York on May 22, 2008 at 1:30 ...presentation, investors and other,interested parti...terMune,s,corporate website at http://www.intermu...
Other Biology Technology:Direct Medical Systems Reaches Profitability in 2-1/2 Years, as a Result of Sales of the World's Smallest and Lightest Ultrasound System, the InNovaSound USB Ultrasound. 2Immunosyn Corporation Files 10-Q 2Immunosyn Corporation Files 10-Q 3
(Date:11/24/2009)...held secrets of the earth,s history locked in its ...y little information on the environments that have...years. Now, a team of researchers from nine instit...e of $10 million dollars by the National Science F... literally. These scientists will drill through th...
(Date:11/23/2009)...ociated strain of the deadly superbug MRSAan infec...ibioticsposes a far greater health threat than pre..., according to a study in the December issue of E...is easily picked up in fitness centers, schools, a...ll burden of MRSA within hospitals, the report fou...
(Date:11/23/2009)...ggests that a common oral bacterium may exacerbate...s et al, "Unique Lipids from a Common Human Bacter...of Enhancing Autoimmunity," appears in the Decembe... . , Multiple sclerosis (MS), a disease where th... affects nearly 1 in 700 people in the United Stat...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 1Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 2Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 3Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 4Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 1Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 2Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 3Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 1Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 2
...more than half of children with sore throat, excee...used nonrecommended antibiotics for 27 percent of ...according to a study in the November 9 issue of JA...ounts for 6 percent of visits by children to famil... to background information in the article. The mos...
...e have demonstrated that Langerhans cells in the s...stem to pathogens, instead dampen the skin,s react...potential to significantly alter understanding of ... as psoriasis, lupus and skin cancer. , Dendriti...emely efficient at alerting the immune system to t...
...iated with an increased risk of hypertension in wo...nsumption of sugared or diet colas, according to a...ately 50 million people in the United States have ...cording to background information in the article. ...eart disease, stroke, and congestive heart failure...
Other Biology News:Children overprescribed antibiotics for sore throat 2Langerhans cells regulate immune reactions in the skin 2No link found between caffeine intake and development of hypertension in women 2
Hae III (High Concentration) from Takara Mirus Bio
Sma I (High Concentration) from Takara Mirus Bio
2 ml SmartScan Racks from ABgene
Mouse Anti-beta-III-Tubulin Monoclonal Antibody, Unconjugated, Clone TU-20 from BioVendor Laboratory Medicine, Inc.
Biology Products: